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Abstract 
 
Frantz’ tumour of the pancreas is also known as solid pseudopapillary tumour (SPT) of the pancreas. It is a rare 
pancreatic neoplasm and represents about 3% of all the pancreatic cystic neoplasm. It occurs predominantly in young 
woman in 2nd to 3rd decade of life. These tumours exhibit indolent behaviour and very often reach considerable size 
before the first symptoms appear. Despite this presentation these tumours have low malignant potential and complete 
surgical resection render excellent prognosis. We reported a case of a 16-year-old girl who presented with upper 
abdominal mass with symptoms of gastric outlet obstruction for 7 months duration. Clinical examination revealed a 
huge epigastric mass measuring 10 x 12 cm in size. CT scan showed presence of mass arising from the body of the 
pancreas which was hypervascular, well-encapsulated with mixed cystic and solid components. She then underwent 
successful distal pancreatectomy and splenectomy and recovered uneventfully. 
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Introduction 
 
Solid Pseudopapillary Tumour (SPT) of the pancreas 
accounts for about 3% of the pancreatic cystic tumours 
(1). The first published description of pseudopapillary 
tumour was by Frantz in 1959 (2). This lesion is also 
named as Frantz tumours, solid and papillary tumours, 
papillary cystic tumours, solid cystic tumours or 
Hamoudi tumours. It usually occurs in female in 2nd 
and 3rd of life and the most common location of the 
tumour is at the head of pancreas (3). Unlike ductal 
adenocarcinoma of the pancreas, SPT rarely causes 
obstructive jaundice. The most common presentations 
are due to mass effect to the surrounding viscera such 
as early satiety and vomiting. 
 
 
Case Report 
 
A 16-year-old female presented with epigastric 
discomfort for the past 7 months associated with early 
satiety and postprandial emesis. She denied any 
symptoms of jaundice and complained of weight loss 
of 10 kg in 7 months duration. Physical examination 
revealed mild epigastric tenderness and a palpable 
mass about 10 x 12 cm in size. 
 
Routine laboratory test results were unremarkable and 
tumour marker levels (carcinoembryogenic antigen, 
alpha-fetoprotein, CA 19-9) were within normal limits. 
In view of the symptoms of gastric outlet obstruction, 
oesophagogastroduodenoscopy (OGDS) was then
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Figure 1: Computed tomography showed pancreatic lesion 
with mixed solid cystic component involving the body and 
tail of pancreas likely represent solid pseudopapillary tumour 
with left sided portal hypertension. 
 
 
Figure 2: Resected specimen consisted of tumour of the 
distal pancreas and spleen 
 
performed and revealed external compression to the 
body of stomach causing pylorus narrowing. CT scan 
showed a well encapsulated pancreatic body mass with 
mixed cystic and solid component causing 
compression to the surrounding structures with 
splenomegaly (Fig. 1). Celiac angiography revealed no 
invasion of vasculatures by the tumour.  
 
She underwent distal pancreatectomy and splenectomy 
(Fig. 2). Laparotomy revealed a tail of pancreas mass 
with no surrounding infiltration except at the portal 
vein where tumour was shaved off .There was no 
evidence of intra-abdominal metastasis.  
 
Her postoperative recovery was uneventful and she 
was discharged after 1 week of admission. 
Histopathology review of the pancreatic mass revealed 
a well-circumscribed mass with capsular invasion. Cut 
section shows a heterogenous, necrotic and 
haemorrhagic surface with central cavitation and clear 
resection margin. Histopathologically it showed 
encapsulated mass with sheets of tumour cells within  
 
Figure 3: Histopathological picture shows encapsulated 
mass with sheets of tumour cells within. 
 
(Fig. 3).  The presence of pseudo papillary structure 
confirmed the diagnosis of solid pseudopapillary 
tumour. There were no pleomorphisms or mitotic 
activity seen to suggest benign behaviour. 
Immunohistochemistry test were positive for vimentin 
and CD10. The resected margins are clear except for 
portal vein site which is near margin less than 0.1 mm. 
 
Discussion 
 
Solid pseudopapillary tumour (SPT) is believed to 
arise from ductal or acinar origin. It is a tumour with 
low malignant potential. Most common sites were at 
the tail of pancreas (35.9%) as presented in our patient, 
followed by the head (34%) and other parts of 
pancreas (3). This rare SPT usually affects female 
patients in the second or third decades of life. 
However, our patient presented at earlier age which 
was 16 years old. 
 
Lack of specific clinical symptoms is typical of this 
tumour as in the case presented. In the past, 
approximately 80% of patients with SPT presented late 
secondary to compressive symptoms. However, 
incidental detection of SPT is becoming more common 
with widespread use of cross sectional imaging, and it 
now accounts for up to 50% of cases. Patients 
commonly presented with nonspecific symptoms of 
abdominal pain, followed by nausea, vomiting, and 
weight loss (4). Other symptoms that occur less 
frequently include gastrointestinal obstruction, anemia, 
jaundice, and pancreatitis. Patients may also present 
with a palpable mass. Our patient had significant 
weight loss as the result of compression of the 
pancreatic mass to the stomach causing early satiety 
and reduce oral intake. 
 
The finding of a mixed solid and cystic pancreatic 
lesion on cross sectional imaging in a young woman 
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should raise the suspicion of a SPT. The lesions may 
appear as well demarcated solid tumors in Magnetic 
Resonance Imaging (MRI) (5). The tumour is usually 
found to be a vascular or hypovascular from arterial 
phase of CT, which contradicted with the finding in 
this case hence celiac arteriography was performed to 
delineate the vasculatures prior to surgical intervention 
(3). The arteriography was performed in this case to 
look for any neovascularization due to enlarged 
tumours, possible major vessels thrombosis like 
gastroduodenal artery or pancreaticoduodenal arteries 
causing formation of collateral vessels as well as to 
determine for any possibility of angioembolization to 
shrink the tumour before operation. In this case the 
angioembolization was not performed because there 
was no main feeding vessel to supply the tumour. 
 
Although endoscopic ultrasound (EUS) with fine 
needle aspiration (FNA) can be used as an adjunct to 
achieve confirmatory diagnosis, we obviate the 
intention in this case as the clinical presentation 
correlates well with the radiological finding and 
histological diagnosis will not change the treatment 
option. Furthermore, nature of this low malignant 
lesion and potential of seedling during FNA should be 
weighted (6). According to the 2015 guideline from 
the American Gastroenterological Association (AGA), 
EUS is not recommended if the lesion is less than 3 cm 
with no evidence of ductal dilation or solid component 
within the cyst. The typical appearance of SPT on 
endoscopic ultrasound (EUS) is a well demarcated, 
hypoechogenic, solid cystic appearing mass and 
irregular calcifications occasionally present in up to 20 
percent of cases (7). 
 
The malignant potential of solid pseudopapillary 
neoplasms has not been well studied. However, 
tumour size ≥  5 cm was associated with an increased 
risk of high grade malignancy. Given the lesion's 
malignant potential, combined with its good prognosis 
if resected, the finding of a pancreatic mixed solid and 
cystic lesion in a young woman on CT or MRI should 
lead to the suspicion of SPT until proven otherwise. 
 
The type of operations depends mainly on the location 
of the tumour. Pylorus preserving 
pancreaticoduodenectomy or classical Whipple 
procedure are the operations for SPT at the head; and 
distal pancreatectomy with or without splenectomy for 
tumours distal to neck of the pancreas. Resection of 
only midportion of the pancreas leaving the head and 
the tail of pancreas can be done for tumours at the 
body of pancreas (3). 
 
We performed distal pancreatectomy with 
splenectomy because this tumour has risk of malignant 
transformation thus we needed to ligate the splenic 
vessels to facilitate resection with possible free margin 
at the pancreatic bed. Furthermore, splenic 
preservation is technically difficult especially in long 
standing large tumours. The patient was preoperatively 
vaccinized and consented for splenectomy prior to the 
operation. 
 
Unlike the criteria for resection of pancreatic 
adenocarcinoma, invasion to portal vein and superior 
mesenteric artery are not an absolute contraindication 
for resection as options like portal vein resection with 
reconstruction or tumour shavings from these vessels 
are acceptable (3). 
 
We decided to shave the tumour from the portal vein 
rather than portal vein resection and reconstruction 
because resection of this vein carries higher morbidity 
especially ischeamic hepatitis or superior mesenteric 
vein thrombosis. Even patients with residual disease or 
metastases have been reported to have long-term 
survival following surgical treatment.  
 
The role of chemoradiation therapy is very limited due 
to its poor response. It is only reserved to those 
unresectable tumours. Inpatients with liver metastasis, 
some reports advocated for Trans Arterial Chemo 
Embolization as palliative role of therapy (3). 
 
The cut section of SPT macroscopically will show a 
well encapsulated tumour with solid and cystic 
compositions. Some areas of haemorrhages and central 
necrosis will be seen. The main character of the 
tumour is the presence of both solid and 
pseudopapillary structures. 
 
Microscopically, the tumour exhibits characterictic 
branching papillae with myxoidstroma. Special stains, 
including vimentin, CD10 and betacatenin may be 
used to differentiate an SPT from a pancreatic 
neuroendocrine tumour (3).  
 
SPT is regarded as benign tumour with low malignant 
potential and less than 5% risk of local recurrence (8). 
The tumour is usually operable at presentation unless 
it shows local vascular invasion or distant metastases, 
usually to the liver and peritoneum (3). 
 
Conclusion 
 
In summary, SPT of the pancreas should be treated 
surgically with curative intent as these tumour carries 
risk of malignant potential. Furthermore, the risk of 
recurrence after resection is very low and it carries 
good long term prognosis. 
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